查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591892

人體生長荷爾蒙市場：按給藥途徑、類型、分佈和應用分類 - 2025-2030 年全球預測

Human Growth Hormone Market by Route of Administration (Intramuscular, Intravenous, Oral), Type (Amino Acid Derivatives, Peptide Hormones, Steroid Hormones), Distribution, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人體生長荷爾蒙市場價值為57.7億美元，預計2024年將達到62.8億美元，複合年成長率為8.87%，到2030年將達到104.6億美元。

人體生長荷爾蒙(HGH) 是醫療和治療應用的重要成分，涉及多種市場，包括治療應用、抗衰老治療、健身和性能增強。將其納入針對兒童和成人生長激素缺乏症、透納氏症、普瑞德-威利症候群和慢性腎臟病的應對措施中，強調了其在醫療保健中的需求。它的用途通常延伸到美容和運動領域，用於肌肉生長和修復。最終使用範圍主要是醫院、診所和健身中心。市場成長主要受到醫療保健意識提高、重組 DNA 技術進步、慢性病盛行率增加以及美容和運動領域採用率上升的影響。關鍵的商機在於將穿戴式技術整合到個人化醫療和健康追蹤中，以回應日益成長的健康意識。然而，這個市場面臨著高昂的治療成本、嚴格的法律規範、潛在的副作用以及圍繞非治療用途的倫理問題的限制。在運動中濫用 HGH 和不受監管的分銷管道是主要挑戰。

主要市場統計
基準年[2023] 57.7億美元
預計年份 [2024] 62.8億美元
預測年份 [2030] 104.6億美元
複合年成長率（%） 8.87%

對於市場相關人員來說，生物相似藥激素的開拓可以促進創新、降低成本並提高可及性。專注於最佳化劑量和給藥方法（例如緩釋性）的研究具有廣泛的成長潛力。此外，利用人工智慧提供針對患者的解決方案並擴大其在與老齡化相關的治療中的應用可能會推動市場擴張。該市場本質上是動態的，受到醫療保健進步的推動，但受到監管環境的阻礙。這一領域的成功需要與國際醫療標準保持一致，並積極參與治療用途的道德遊說。因此，持續投資研發以及與醫療保健提供者建立策略夥伴關係對於克服限制並抓住新機會至關重要。

市場動態：揭示快速發展的人體生長荷爾蒙市場的關鍵市場洞察

供需的動態交互作用正在改變人體生長荷爾蒙市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 與荷爾蒙失調相關的病例迅速增加
    • 增加報銷政策
    • 生長激素缺乏症增加
  • 市場限制因素
    • 人體生長荷爾蒙治療的高成本
  • 市場機會
    • 市面上人體生長荷爾蒙產品數量增加
    • 私營和公共部門的研發資金迅速增加
  • 市場挑戰
    • 人體生長荷爾蒙療法對人體的不良影響

波特五力：駕馭人體生長荷爾蒙市場的策略工具

波特的五力框架是了解人體生長荷爾蒙市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對人體生長荷爾蒙市場的影響

外部宏觀環境因素在塑造人體生長荷爾蒙市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人體生長荷爾蒙市場的競爭狀況

人體生長荷爾蒙市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣人體生長荷爾蒙市場供應商的績效評估

FPNV 定位矩陣是評估人體生長荷爾蒙市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製人體生長荷爾蒙市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對人體生長荷爾蒙市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 與荷爾蒙失調相關的病例迅速增加
      • 擴大贖回政策
      • 生長激素缺乏症增加
    • 抑制因素
      • 與人體生長荷爾蒙治療程序相關的費用很高
    • 機會
      • 人體生長荷爾蒙產品上市數量增加
      • 私營和公共部門的研發資金迅速增加
    • 任務
      • 人體生長荷爾蒙療法對人體的不良影響
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人體生長荷爾蒙市場：依給藥途徑

  • 肌肉注射
  • 靜脈
  • 口服
  • 皮下的

第7章人體生長荷爾蒙市場：依類型

  • 胺基酸衍生物
  • 肽激素
  • 類固醇激素

第8章人體生長荷爾蒙市場經銷商

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章人體生長荷爾蒙市場：依應用

  • 生長激素缺乏症
  • 普瑞德威利症候群
  • 透納氏症

第10章美洲人體生長荷爾蒙市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區人體生長荷爾蒙市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲人體生長荷爾蒙市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aeterna Zentaris, inc.
  • Anhui Anke Biotechnology Co., Ltd
  • Biopartners GmbH
  • Eli Lilly and Company
  • Ferring BV
  • GeneScience Pharmaceuticals Co., Ltd
  • Ipsen SA
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Roche Holdings, Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Limited
Product Code: MRR-43127F7278D3

The Human Growth Hormone Market was valued at USD 5.77 billion in 2023, expected to reach USD 6.28 billion in 2024, and is projected to grow at a CAGR of 8.87%, to USD 10.46 billion by 2030.

Human Growth Hormone (HGH), a critical component in medical and therapeutic applications, spans a diverse market encompassing therapeutic uses, anti-aging treatments, fitness, and performance enhancement. Its inclusion in addressing growth hormone deficiency in children and adults, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease underscores its necessity in healthcare. The application often extends to aesthetics and athletic realms, where it is utilized for muscle growth and repair. The end-use scope predominantly covers hospitals, clinics, and fitness centers. Market growth is chiefly influenced by rising healthcare awareness, advancements in recombinant DNA technologies, increased prevalence of chronic ailments, and heightened adoption in aesthetic and athletic sectors. Key opportunities lie in personalized medicine and the integration of wearable technology for health tracking, catering to an increasingly health-conscious population. Nonetheless, this market faces limitations due to high treatment costs, stringent regulatory frameworks, potential side effects, and ethical concerns surrounding non-therapeutic use. The misuse of HGH in sports and unregulated distribution channels poses significant challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 5.77 billion
Estimated Year [2024] USD 6.28 billion
Forecast Year [2030] USD 10.46 billion
CAGR (%) 8.87%

For market players, innovation can thrive through the development of biosimilar hormones, potentially reducing costs and increasing accessibility. Research focusing on optimizing dosage and administration methods, such as sustained-release formulations, holds promising growth potential. Additionally, leveraging AI for patient-specific solutions and expanding applications for age-related treatment can propel market expansion. The market reveals a dynamic nature, driven by healthcare advancements but hindered by regulatory landscapes. Successful navigation in this domain requires harmonization with international health standards and proactive participation in ethical lobbying for therapeutic-focused use. As such, continued investment in R&D and strategic partnerships with healthcare providers are critical to overcoming limitations and seizing emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Growth Hormone Market

The Human Growth Hormone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in the cases related to the hormonal disorders
    • Increase in the reimbursement policies
    • Growing growth hormone deficiency disorders
  • Market Restraints
    • Cost related to human growth hormone therapies procedures is high
  • Market Opportunities
    • Growing number of product launches of the human growth hormone
    • Surge in research and development fundings from the private as well as public sector
  • Market Challenges
    • Adverse impact of human growth hormone therapies on human bodies

Porter's Five Forces: A Strategic Tool for Navigating the Human Growth Hormone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Growth Hormone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Growth Hormone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Growth Hormone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Growth Hormone Market

A detailed market share analysis in the Human Growth Hormone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Growth Hormone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Growth Hormone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Growth Hormone Market

A strategic analysis of the Human Growth Hormone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Growth Hormone Market, highlighting leading vendors and their innovative profiles. These include Aeterna Zentaris, inc., Anhui Anke Biotechnology Co., Ltd, Biopartners GmbH, Eli Lilly and Company, Ferring B.V., GeneScience Pharmaceuticals Co., Ltd, Ipsen S.A, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Roche Holdings, Inc., Sandoz International GmbH, and Teva Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Human Growth Hormone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Intramuscular, Intravenous, Oral, and Subcutaneous.
  • Based on Type, market is studied across Amino Acid Derivatives, Peptide Hormones, and Steroid Hormones.
  • Based on Distribution, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Application, market is studied across Growth Hormone Deficiency, Prader-Willi Syndrome, and Turner Syndrome.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the cases related to the hormonal disorders
      • 5.1.1.2. Increase in the reimbursement policies
      • 5.1.1.3. Growing growth hormone deficiency disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Cost related to human growth hormone therapies procedures is high
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing number of product launches of the human growth hormone
      • 5.1.3.2. Surge in research and development fundings from the private as well as public sector
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse impact of human growth hormone therapies on human bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Growth Hormone Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intramuscular
  • 6.3. Intravenous
  • 6.4. Oral
  • 6.5. Subcutaneous

7. Human Growth Hormone Market, by Type

  • 7.1. Introduction
  • 7.2. Amino Acid Derivatives
  • 7.3. Peptide Hormones
  • 7.4. Steroid Hormones

8. Human Growth Hormone Market, by Distribution

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Human Growth Hormone Market, by Application

  • 9.1. Introduction
  • 9.2. Growth Hormone Deficiency
  • 9.3. Prader-Willi Syndrome
  • 9.4. Turner Syndrome

10. Americas Human Growth Hormone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Human Growth Hormone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Human Growth Hormone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aeterna Zentaris, inc.
  • 2. Anhui Anke Biotechnology Co., Ltd
  • 3. Biopartners GmbH
  • 4. Eli Lilly and Company
  • 5. Ferring B.V.
  • 6. GeneScience Pharmaceuticals Co., Ltd
  • 7. Ipsen S.A
  • 8. Merck KGaA
  • 9. Novartis AG
  • 10. Novo Nordisk A/S
  • 11. Pfizer Inc.
  • 12. Roche Holdings, Inc.
  • 13. Sandoz International GmbH
  • 14. Teva Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. HUMAN GROWTH HORMONE MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN GROWTH HORMONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN GROWTH HORMONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN GROWTH HORMONE MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY AMINO ACID DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY STEROID HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY PRADER-WILLI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TURNER SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2023